Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · IEX Real-Time Price · USD
38.24
-0.34 (-0.88%)
At close: May 17, 2024, 4:00 PM
36.56
-1.68 (-4.39%)
After-hours: May 17, 2024, 5:43 PM EDT
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $1.45 billion as of May 17, 2024. Its market cap has increased by 217.63% in one year.
Market Cap
1.45B
Enterprise Value
1.18B
1-Year Change
217.63%
Ranking
Category
Stock Price
$38.24
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $1.45B, an increase of 371.38%. That is a compound annual growth rate of 54.09%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 1.44B | -0.88% |
May 16, 2024 | 1.46B | 0.21% |
May 15, 2024 | 1.45B | 1.34% |
May 14, 2024 | 1.44B | -0.99% |
May 13, 2024 | 1.45B | 3.71% |
May 10, 2024 | 1.40B | 8.69% |
May 9, 2024 | 1.29B | -8.86% |
May 8, 2024 | 1.41B | 8.44% |
May 7, 2024 | 1.30B | 2.70% |
May 6, 2024 | 1.27B | 0.48% |
May 3, 2024 | 1.26B | 6.41% |
May 2, 2024 | 1.19B | 6.58% |
May 1, 2024 | 1.11B | 3.38% |
Apr 30, 2024 | 1.08B | -2.15% |
Apr 29, 2024 | 1.10B | 0.25% |
Apr 26, 2024 | 1.10B | -0.53% |
Apr 25, 2024 | 1.10B | -1.68% |
Apr 24, 2024 | 1.12B | -2.82% |
Apr 23, 2024 | 1.15B | 4.40% |
Apr 22, 2024 | 1.10B | -0.47% |
Apr 19, 2024 | 1.11B | -1.25% |
Apr 18, 2024 | 1.12B | -4.56% |
Apr 17, 2024 | 1.18B | -1.37% |
Apr 16, 2024 | 1.19B | -0.12% |
Apr 15, 2024 | 1.20B | -3.40% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Maravai LifeSciences Holdings | 1.48B |
Dynavax Technologies | 1.48B |
Pacira BioSciences | 1.47B |
Owens & Minor | 1.46B |
Omnicell | 1.46B |
Akero Therapeutics | 1.43B |
Kiniksa Pharmaceuticals | 1.43B |
Day One Biopharmaceuticals | 1.40B |